These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6018139)
41. [Diagnostic criterion and management of burn sepsis]. Yao YM; Chai JK; Sheng ZY Zhonghua Shao Shang Za Zhi; 2003 Apr; 19(2):65-6. PubMed ID: 12830800 [No Abstract] [Full Text] [Related]
42. [The present status, counter-measures and new trends on burn infection]. Xiao GX Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):81-3. PubMed ID: 17649876 [TBL] [Abstract][Full Text] [Related]
43. Mortality and causes of death in a burn centre. Bloemsma GC; Dokter J; Boxma H; Oen IM Burns; 2008 Dec; 34(8):1103-7. PubMed ID: 18538932 [TBL] [Abstract][Full Text] [Related]
44. Anti-infective drugs in the prevention and treatment of sepsis syndrome. Beam TR Crit Care Nurs Clin North Am; 1994 Jun; 6(2):275-93. PubMed ID: 7946188 [TBL] [Abstract][Full Text] [Related]
45. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus. De Beeck VO; Dhif N; Philipp J; De Bels D J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858 [No Abstract] [Full Text] [Related]
46. Staphylococcal bacteremia and endocarditis: state of the art. Bayer AS Arch Intern Med; 1982 Jun; 142(6):1169-77. PubMed ID: 6807232 [TBL] [Abstract][Full Text] [Related]
47. [Effect of tobramycin on the bacterial flora of burn wounds]. Zietkiewicz W; Nasiłowski W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Grochowska A Pol Tyg Lek; 1981 Aug; 36(32):1239-41. PubMed ID: 7322940 [No Abstract] [Full Text] [Related]
48. [N1-metal sulfa drugs and zincpolyanemine and its derivatives in prevention of burn wound sepsis]. Ge SD Zhonghua Wai Ke Za Zhi; 1982 May; 20(5):264-6. PubMed ID: 7128331 [No Abstract] [Full Text] [Related]
49. [Various aspects of bacterial infections in infants]. Jankowski A Przegl Epidemiol; 1981; 35(3):319-25. PubMed ID: 7330240 [No Abstract] [Full Text] [Related]
50. [Bacteremia in 1977-78. Bacterial diagnoses and antibiotic sensitivity]. Bruun B; Sloth K; Bentzon MW; Frederiksen W Ugeskr Laeger; 1983 Apr; 145(14):1059-62. PubMed ID: 6346626 [No Abstract] [Full Text] [Related]
52. The control of burn wound sepsis by the use of quantitative bacteriologic studies and subeschar clysis with antibiotics. Baxter CR; Curreri PW; Marvin JA Surg Clin North Am; 1973 Dec; 53(6):1509-18. PubMed ID: 4586477 [No Abstract] [Full Text] [Related]
53. Sixth National Burn Seminar. Bleeding in children. Dimick A J Trauma; 1967 Jan; 7(1):119-20. PubMed ID: 6018119 [No Abstract] [Full Text] [Related]
54. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus. De Gascun C; Rajan L; O'Neill E; Smyth EG J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085 [No Abstract] [Full Text] [Related]
55. Sixth National Burn Seminar. Hypertension in children with burns. Lowrey GH J Trauma; 1967 Jan; 7(1):140-4. PubMed ID: 6019082 [No Abstract] [Full Text] [Related]
56. The choice of antimicrobial drugs. Med Lett Drugs Ther; 1984 Mar; 26(656):19-26. PubMed ID: 6700533 [No Abstract] [Full Text] [Related]
57. [Antibiotics to newborn infants with sepsis: effect and ecology]. Kolmos HJ; Jensen TG Ugeskr Laeger; 2001 Mar; 163(11):1574. PubMed ID: 11268814 [No Abstract] [Full Text] [Related]
58. Infection control for the burn patient. Marvin JA; Einfeldt LE Nurs Clin North Am; 1980 Dec; 15(4):833-42. PubMed ID: 7005877 [TBL] [Abstract][Full Text] [Related]
59. Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Jeschke MG; Chinkes DL; Finnerty CC; Przkora R; Pereira CT; Herndon DN Crit Care Med; 2007 Feb; 35(2):579-83. PubMed ID: 17205022 [TBL] [Abstract][Full Text] [Related]
60. The selective use of systemic antibiotics in the treatment of burns. Wilkins TJ; Bennett JE Surg Gynecol Obstet; 1980 Sep; 151(3):404-6. PubMed ID: 7404315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]